Eli Lilly & Co. vs. Praxis Precision Medicines, Inc. Common Stock
LLY
Eli Lilly & Co.
$1209.00 -0.92%
VS PRAXPraxis Precision Medicines, Inc. Common Stock
$366.81 -0.45%
Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| LLY | PRAX | |
|---|---|---|
| Market Cap | $1.09 trillion | $10.77 billion |
| Revenue (TTM) | — | — |
| Net Income (TTM) | — | $-339,126,000 |
LLY leads on 1 of 1 size & scale factors.
Valuation
| LLY | PRAX | |
|---|---|---|
| Price / Book | — | 8.03 |
LLY and PRAX split the valuation factors evenly.
Profitability
| LLY | PRAX | |
|---|---|---|
| Return on Equity | — | -25.29% |
LLY and PRAX split the profitability factors evenly.
Risk & Sentiment
| LLY | PRAX | |
|---|---|---|
| Short Interest | 1.29% | 1.95% |
LLY leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, PRAX overview, PRAX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.